Low blood pressure in endothelial cell–specific endothelin 1 knockout mice

YY Kisanuki, N Emoto, T Ohuchi, B Widyantoro… - …, 2010 - Am Heart Assoc
Endothelin (ET) 1 is a potent vasoconstrictor peptide produced by vascular endothelial cells
and implicated in various pathophysiologic states involving abnormal vascular tone …

Endothelin and endothelin antagonism: roles in cardiovascular health and disease

P Tamirisa, WH Frishman, A Kumar - American Heart Journal, 1995 - Elsevier
Endothelin is the most potent mammalian vasoconstrictor yet discovered. Its three isoforms
play leading roles in regulating vascular tone and causing mitogenesis. The isoforms bind to …

Endothelin-1 and atherosclerosis: potential complications associated with endothelin-receptor blockade

MR Dashwood, JCS Tsui - Atherosclerosis, 2002 - Elsevier
Atherosclerotic vascular disease remains the single most prevalent cause of death and
morbidity in the western world. Endothelin-1 (ET-1) is a potent vasoconstrictor peptide that …

Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats.

R Lariviere, G Thibault, EL Schiffrin - Hypertension, 1993 - Am Heart Assoc
Endothelin-1 (ET-1) is a powerful vasoconstrictor peptide produced in the endothelium of
blood vessels that may play an important role in the control of local blood flow and could be …

The endothelin family: an overview

T Masaki - Journal of cardiovascular pharmacology, 2000 - journals.lww.com
Endothelin (ET) is a potent vasoconstrictive peptide initially found in the conditioned medium
of cultured endothelial cells (1). It comprises 21 amino acid residues including four cysteine …

Endothelins as cardiovascular peptides

ER Levin - American journal of nephrology, 1996 - karger.com
The normal functional state of the vasculature and the events leading to the development of
significant arterial disease involve the interaction of important vasoactive substances, which …

Pathophysiology of endothelin in the cardiovascular system

T Miyauchi, T Masaki - Annual review of physiology, 1999 - annualreviews.org
▪ Abstract In this article, we review the basic pharmacological and biochemical features of
endothelin and the pathophysiological roles of endothelin in cardiovascular diseases …

Endothelin and the heart in health and diseases

T Miyauchi, S Sakai - Peptides, 2019 - Elsevier
Abstract Endothelin-1 (ET-1), a 21-amino acid peptide, was initially identified in 1988 as a
potent vasoconstrictor and pressor substance isolated from the culture supernatant of …

Endothelin antagonism in pulmonary hypertension, heart failure, and beyond

T Attina, R Camidge, DE Newby, DJ Webb - Heart, 2005 - heart.bmj.com
The discovery in 1988 of endothelin-1 (ET-1) by Yanagisawa and colleagues in Japan
represented a landmark in the field of cardiovascular research. 1 A combination of molecular …

Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs

TF Luscher, M Barton - Circulation, 2000 - Am Heart Assoc
The 21-amino acid peptide endothelin-1 (ET-1) is the predominant isoform of the endothelin
peptide family, which includes ET-2, ET-3, and ET-4. It exerts various biological effects …